Brivepsy 50mg Tab

BRIVEPSY 50MG TAB by CIPLA CRITICAL CARE

BRIVEPSY 50MG Tablet is an anti-epileptic medication manufactured by Cipla Critical Care. It is used to manage partial-onset seizures in individuals with epilepsy.

• Name:
  • Brand Name: BRIVEPSY 50MG TAB
  • Common Name: Brivaracetam
• Composition:
  • Each tablet contains Brivaracetam 50 mg as the active ingredient.
• Uses:
  • BRIVEPSY is prescribed for the treatment of partial-onset seizures (also known as focal onset seizures) in patients with epilepsy, typically in adults and children aged 1 month and older.
  • It works by selectively binding to synaptic vesicle protein 2A (SV2A) in the brain, which helps to stabilize abnormal electrical activity in nerve cells and prevent the spread of electrical signals that cause seizures.
  • It can be used alone or as an add-on therapy with other anti-epileptic medicines.
• Dosage and Administration:
  • For adults (16 years or older), the recommended starting dose is typically 50 mg twice daily (100 mg per day).
  • The dose may be adjusted by a healthcare provider based on individual patient tolerability and therapeutic response, usually ranging from 25 mg to 100 mg twice daily (50 mg to 200 mg/day).
  • Pediatric dosing (for patients weighing less than 50 kg or under 16 years) is dependent on body weight.
  • Tablets should be swallowed whole with a liquid, with or without food. They should not be chewed or crushed.
  • It is generally advised as a long-term treatment, and patients should continue taking it as prescribed, even if they feel well. Abrupt discontinuation can lead to worsening seizures.
• Side Effects:
  • Common Side Effects: Drowsiness, excessive sleepiness, fatigue, dizziness, nausea, and vomiting. These often occur at the start of treatment or after a dose increase and may resolve over time.
  • Serious Side Effects:
    • Mood and behavior changes, including anxiety, nervousness, confusion, hallucinations, irritability, hostility, depression, and suicidal thoughts or behavior.
    • Serious allergic reactions (skin rash, itching, hives, swelling of the face, lips, tongue, or throat).
    • Serious dermatologic reactions such as severe skin rashes with blisters and peeling skin (e.g., Stevens-Johnson syndrome).
• Precautions:
  • Monitor for changes in mood, behavior, or suicidal thoughts, especially when starting the medication or changing the dose.
  • Brivaracetam can cause drowsiness, dizziness, and problems with balance and coordination. Patients should be advised not to drive or operate machinery until they know how it affects them.
  • Inform your doctor if you have liver problems, as dosage adjustments may be necessary.
  • Caution is advised when co-administering with other CNS depressants, as it can increase sedation.
  • Avoid St. John's Wort and Rifampicin, as they can interact with Brivaracetam.
  • Discuss with your doctor if you are pregnant, planning to become pregnant, or breastfeeding, as the effects on the unborn baby and breast milk are not fully known.
• Storage:
  • Store at room temperature, typically between 15°C to 30°C (59°F to 86°F).
  • Keep out of the reach of children.

BRIVEPSY 50MG TAB by CIPLA CRITICAL CARE contains brivaracetam, an anti-epileptic medication. It is primarily used to treat partial-onset seizures in patients with epilepsy.

Here are some frequently asked questions about BRIVEPSY 50MG TAB:

What is BRIVEPSY 50MG TAB used for?

BRIVEPSY 50MG TAB is used to manage partial-onset seizures (seizures that begin in a specific area of the brain) in individuals with epilepsy. It can be used alone or in combination with other anti-epileptic drugs in adults and children aged 1 month and older.

How does BRIVEPSY 50MG TAB work?

BRIVEPSY 50MG TAB contains brivaracetam, which is believed to work by binding with high affinity to synaptic vesicle glycoprotein 2A (SV2A) in the brain. This protein is involved in the release of neurotransmitters, which are chemicals that transmit signals in the brain. By binding to SV2A, brivaracetam helps to stabilize nerve cell activity and reduce the excessive electrical signals that trigger seizures.

What is the usual dosage for BRIVEPSY 50MG TAB?

For adults and adolescents 16 years of age and older, the recommended starting dose is typically 50 mg twice daily. Based on individual patient response and tolerability, the dose may be adjusted between 25 mg and 100 mg twice daily. For children aged 1 month to less than 16 years, the dosage is determined by body weight. It is crucial to follow your doctor's instructions for dosage and not to change it without consulting them.

What are the possible side effects of BRIVEPSY 50MG TAB?

Common side effects can include drowsiness, dizziness, fatigue, nausea, and vomiting. More serious, but less common, side effects may include changes in mood or behavior (such as depression, anxiety, aggression, or suicidal thoughts), problems with coordination, and hypersensitivity reactions (like bronchospasm or angioedema). If you experience any severe or concerning side effects, contact your doctor immediately.

Is BRIVEPSY 50MG TAB safe during pregnancy or breastfeeding?

Pregnancy: It is not known if brivaracetam will harm an unborn baby. If you become pregnant while taking BRIVEPSY 50MG TAB, inform your doctor immediately. You and your doctor will need to weigh the potential risks and benefits. Breastfeeding: Brivaracetam is present in breast milk. It is important to discuss with your healthcare provider if you are breastfeeding or plan to breastfeed, as the infant should be monitored for drowsiness, agitation, adequate weight gain, and developmental milestones.

Can BRIVEPSY 50MG TAB be taken with other medications?

BRIVEPSY 50MG TAB can interact with other medications. For example, co-administration with carbamazepine, phenytoin, or phenobarbital/primidone may lower brivaracetam plasma concentrations. Rifampin can also reduce brivaracetam exposure, potentially requiring a dose increase of brivaracetam. Brivaracetam may also increase the levels of carbamazepine epoxide (an active metabolite of carbamazepine). It's crucial to inform your doctor about all prescription and over-the-counter medicines, vitamins, and herbal supplements you are taking to avoid potential interactions.

What precautions should be taken?

Do not stop taking BRIVEPSY 50MG TAB suddenly, as this can lead to an increase in seizure frequency or status epilepticus (a prolonged seizure). Your doctor will likely advise a gradual reduction in dosage if the medicine needs to be discontinued. This medication can cause drowsiness, dizziness, and coordination problems, so avoid driving or operating machinery until you know how it affects you. Individuals with a history of depression, mood problems, suicidal thoughts, or liver problems should discuss these with their doctor before starting this medication.

What happens if a dose is missed?

If you miss a dose of BRIVEPSY 50MG TAB, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. If you are unsure, consult your healthcare provider.

How should it be stored?

BRIVEPSY 50MG TAB tablets should be stored in a closed container at room temperature, generally between 59°F to 86°F (15°C to 30°C), away from heat, moisture, and direct light. Do not freeze the oral solution. Any unused oral solution should be discarded 5 months after first opening the bottle. Keep all medicines out of the reach of children.